Literature DB >> 27238472

Definitive Chemoradiotherapy ("Watch-and-Wait" Approach).

Karyn A Goodman1.   

Abstract

Preoperative chemoradiotherapy (CRT) followed by total mesorectal excision has been the standard of care for locally advanced patients with rectal cancer. Some patients achieve a pathologic complete response (pCR) to CRT and the oncologic outcomes are particularly favorable in this group. The role of surgery in patients with a pCR is now being questioned as radical rectal resection is associated with significant morbidity and long-term effects on quality of life. In an attempt to better tailor therapy, there is an interest in a "watch-and-wait" approach in patients who have a clinical complete response (cCR) after CRT with the goal of omitting surgery and allowing for organ preservation. However, a cCR does not always indicate a pCR, and improved clinical and imaging modalities are needed to better predict which patients have achieved a pCR and therefore can safely undergo a "watch-and-wait" approach. This article reviews the current data on nonoperative management and on-going controversies associated with this approach.
Copyright © 2016 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2016        PMID: 27238472     DOI: 10.1016/j.semradonc.2016.02.003

Source DB:  PubMed          Journal:  Semin Radiat Oncol        ISSN: 1053-4296            Impact factor:   5.934


  6 in total

Review 1.  Adaptive radiation dose escalation in rectal adenocarcinoma: a review.

Authors:  Jonathan D Van Wickle; Eric S Paulson; Jerome C Landry; Beth A Erickson; William A Hall
Journal:  J Gastrointest Oncol       Date:  2017-10

Review 2.  Clinical utility of pretreatment prediction of chemoradiotherapy response in rectal cancer: a review.

Authors:  Byong Chul Yoo; Seung-Gu Yeo
Journal:  EPMA J       Date:  2017-03-03       Impact factor: 6.543

3.  Assessing Rectal Cancer Treatment Response Using Coregistered Endorectal Photoacoustic and US Imaging Paired with Deep Learning.

Authors:  Xiandong Leng; K M Shihab Uddin; William Chapman; Hongbo Luo; Sitai Kou; Eghbal Amidi; Guang Yang; Deyali Chatterjee; Anup Shetty; Steve Hunt; Matthew Mutch; Quing Zhu
Journal:  Radiology       Date:  2021-03-23       Impact factor: 11.105

4.  Radiomics features on radiotherapy treatment planning CT can predict patient survival in locally advanced rectal cancer patients.

Authors:  Jiazhou Wang; Lijun Shen; Haoyu Zhong; Zhen Zhou; Panpan Hu; Jiayu Gan; Ruiyan Luo; Weigang Hu; Zhen Zhang
Journal:  Sci Rep       Date:  2019-10-25       Impact factor: 4.379

5.  Carcinoembryonic Antigen Improves the Performance of Magnetic Resonance Imaging in the Prediction of Pathologic Response after Neoadjuvant Chemoradiation for Patients with Rectal Cancer.

Authors:  Gyu Sang Yoo; Hee Chul Park; Jeong Il Yu; Doo Ho Choi; Won Kyung Cho; Young Suk Park; Joon Oh Park; Ho Yeong Lim; Won Ki Kang; Woo Yong Lee; Hee Cheol Kim; Seong Hyeon Yun; Yong Beom Cho; Yoon Ah Park; Kyoung Doo Song; Seok-Hyung Kim; Sang Yun Ha
Journal:  Cancer Res Treat       Date:  2019-09-25       Impact factor: 4.679

6.  Efficacy and safety-in analysis of short-course radiation followed by mFOLFOX-6 plus avelumab for locally advanced rectal adenocarcinoma.

Authors:  Ali Shamseddine; Youssef H Zeidan; Ziad El Husseini; Malek Kreidieh; Monita Al Darazi; Rim Turfa; Joseph Kattan; Ibrahim Khalifeh; Deborah Mukherji; Sally Temraz; Kholoud Alqasem; Rula Amarin; Tala Al Awabdeh; Samer Deeba; Faek Jamali; Issa Mohamad; Mousa Elkhaldi; Faiez Daoud; Mahmoud Al Masri; Ali Dabous; Ahmad Hushki; Omar Jaber; Maya Charafeddine; Fady Geara
Journal:  Radiat Oncol       Date:  2020-10-07       Impact factor: 3.481

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.